Day Eightyone
Some good news hot from twitter right now.
Moderna's Press Release to the investors says Phase 3 trials will begin next month with 30,000 participants. In parallel the company is also going ahead with plans to manufacture 0.5-1 billion doses of 100 μg per year. Lonza is the partner for manufacturing.
The very first volunteer for the Phase I trial had an adverse reaction but still has faith in the vaccine.
Chronicle of a Pandemic Foretold
Moderna's Press Release to the investors says Phase 3 trials will begin next month with 30,000 participants. In parallel the company is also going ahead with plans to manufacture 0.5-1 billion doses of 100 μg per year. Lonza is the partner for manufacturing.
The very first volunteer for the Phase I trial had an adverse reaction but still has faith in the vaccine.
Chronicle of a Pandemic Foretold
Comments
Post a Comment